Tang Bu-jian
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment 3
-
- Protease and Inhibitor Mechanisms 4
- Cancer, Lipids, and Metabolism 2
-
- Peptidase Inhibition and Analysis 2
-
- RNA modifications and cancer 3
- Molecular Biology Techniques and Applications 2
- Glycosylation and Glycoproteins Research 1
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Danrong LiWei ZhangLi LiXiaoxia HuJie ZhouQingdi Quentin LiQi WangQingdi Q. Li
- Journals
- International Journal of Oncology (1 paper)International Journal of Molecular Medicine (1 paper)Oncology Reports (1 paper)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Tang Bu-jian
15 papers receiving 381 citations
Peers
Comparison fields: 5 of 66
- Reproductive Medicine 106
- Cancer Research 120
- Oncology 125
- Obstetrics and Gynecology 26
- Molecular Biology 205
Countries citing papers authored by Tang Bu-jian
This map shows the geographic impact of Tang Bu-jian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tang Bu-jian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tang Bu-jian more than expected).
Fields of papers citing papers by Tang Bu-jian
This network shows the impact of papers produced by Tang Bu-jian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tang Bu-jian. The network helps show where Tang Bu-jian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tang Bu-jian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 106 | |
| 2 | Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis. | 2011 | 33 |
| 3 | 2011 | 25 | |
| 4 | 2011 | 39 | |
| 5 | [Relationship between cathepsin L and invasion and metastasis of ovarian carcinoma cells]. | 2010 | 4 |
| 6 | Expressions and siginificance of cathepsin B and its inhibitor in ovarian cancer tissues | 2008 | 1 |
| 7 | [Relationship between combined multigene detection and response to adjuvant chemotherapy in early-stage non-small cell lung cancer]. | 2008 | 2 |
| 8 | 2007 | 5 | |
| 9 | [Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian cancer cells]. | 2006 | 1 |
| 10 | 2005 | 2 | |
| 11 | 2005 | 12 | |
| 12 | [Establishment of 5 resistant ovarian cancer cell strains and expression of resistance-related genes]. | 2004 | 4 |
| 13 | Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. | 2004 | 120 |
| 14 | 2004 | 23 | |
| 15 | [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]. | 2004 | 8 |
About Tang Bu-jian
Tang Bu-jian is a scholar working on Reproductive Medicine, Cancer Research and Molecular Biology, having authored 15 papers that have together received 385 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (4 papers), Ovarian cancer diagnosis and treatment (3 papers), RNA modifications and cancer (3 papers), Molecular Biology Techniques and Applications (2 papers), Cancer, Lipids, and Metabolism (2 papers), Peptidase Inhibition and Analysis (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Reproductive Medicine (106 citations), Cancer Research (120 citations) and Oncology (125 citations). Tang Bu-jian has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Danrong Li, Wei Zhang, Li Li, Xiaoxia Hu, Jie Zhou, Qingdi Quentin Li, Qi Wang, Qingdi Q. Li, Gangduo Wang and Jinshun Zhao. Their work appears in journals such as International Journal of Oncology, International Journal of Molecular Medicine and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.